| [1] |
Vervloet M，Cozzolino M.Vascular calcification in chronic kidney disease：different bricks in the wall?[J].Kidney Int，2017，91（4）：808-817.
|
| [2] |
Hénaut L，Chillon JM，Kamel S，et al.Updates on the Mechanisms and the Care of Cardiovascular Calcification in Chronic Kidney Disease[J].Semin Nephrol，2018，38（3）：233-250.
|
| [3] |
Yamada S，Giachelli CM.Vascular calcifification in CKDMBD：roles for phosphate，FGF23，and Klotho[J].Bone，2017，100：87-93.
|
| [4] |
Schlieper G，Schurgers L，Brandenburg V，et al.Vascular calcification in chronic kidney disease：An update[J].Nephrol Dial Transplant，2016，31（1）：31-39.
|
| [5] |
Lang F，Leibrock C，Pelzl L，et al.Therapeutic interference with vascular calcifification-lessons from klotho-hypomorphic mice and beyond[J].Fro-nt Endocrinol（Lausanne），2018，9（4）：207.
|
| [6] |
刘保岩，韩金祥，鲁艳芹.基质小泡与血管钙化的关系[J].中华老年医学杂志，2016，35（2）：221-225．
|
| [7] |
Dai XY，Zhao MM，Cai Y，et al.Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release[J].Kidney Int，2013，83（6）：1042-1051.
|
| [8] |
Voelkl J，Tuffaha R，Luong TTD，et al.Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB[J].J Am Soc Nephrol，2018，29（6）：1636-1648.
|
| [9] |
Coscas R，Bensussan M，Jacob MP，et al.Free DNA precipitates calcium phosphate apatite crystals in the arterial wall in vivo[J].Atherosclerosis，2017，25（9）：60-67.
|
| [10] |
Villa-Bellosta R，Hamczyk MR，Andrés V.Novel phosphateactivated macrophages prevent ectopic calcifification by increasing extracellular ATP and pyrophosphate[J].PLoS One，2017，12（3）：e0174998.
|
| [11] |
Yang H，Curinga G，Giachelli CM.Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro[J].Kidney Int，2004，66（6）：2293-2299.
|
| [12] |
Masumoto A，Sonou T，Ohya M，et al.Calcium Overload Accelerates Phosphate-Induced Vascular Calcification Via Pit-1，but not the Calcium-Sensing Receptor[J].J Atheroscler Thromb，2017，24（7）：716-724.
|
| [13] |
Rivara MB，Ravel V，Kalantar-Zadeh K，et al.Uncorrected and Albumin-Corrected Calcium，Phosphorus，and Mortali-ty in Patients Undergoing Maintenance Dialysis[J].J Am Soc Nephrol，2015，26（7）：1671-1681.
|
| [14] |
Kazmi AS，Wall BM.Reversible congestive heart failure related to profound hypocalcemia secondary to hypoparathyroidism[J].Am J Med Sci，2007，333（4）：226-229.
|
| [15] |
Portillo MR，Rodríguez-Ortiz ME.Secondary Hyperparthyroidism：Pathogenesis，Diagnosis，Preventive and Therapeutic Strategies[J].Rev Endocr Metab Disord，2017，18（1）：79-95.
|
| [16] |
Iguchi A，Watanabe Y，Iino N，et al.Serum magnesium concentration is inversely associated with fibroblast growth factor 23 in hemodialysis patients[J].Nephrology，2014，19（11）：667-671.
|
| [17] |
Kazmi AS，Wall BM.Reversible congestive heart failure related to profound hypocalcemia secondary to hypoparathyroidism[J].Am J Med Sci，2007，333（4）：226-229.
|
| [18] |
Di Lullo L，Gorini A，Bellasi A，et al.Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease[J].Clin Kidney J，2015，8（6）：732-736.
|
| [19] |
Chang JR，Guo J，Wang Y，et al.Intermedin1-53 attenuates vascular calcifification in rats with chronic kidney disease by upregulation of α-Klotho[J].Kidney Int，2016，89（6）：586-600.
|
| [20] |
Ndip A，Williams A，Jude EB，et al.The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charco neuroarthropathy[J].Diabetes，2011，60（8）：2187-2196.
|
| [21] |
Briet M，Burns KD.Chronic kidney disease and vascular remodelling：molecular mechanisms and clinical implications[J].Clin Sci，2012，123（7）：399-416.
|
| [22] |
Goldfarb S，Martin K.Disorders of divalent ions，renal bone disease and nephrolithiasis[J].Nephrol Self Assess Program，2018，17（3）：205-209.
|
| [23] |
Kukida M，Mogi M，Kan-No H，et al.AT2 receptor stimulation inhibits phosphate-induced vascular calcifification[J].Kidney Int，2019，95（1）：138-148.
|
| [24] |
Chung S，Kim M，Koh ES，et al.Serum 1，25-dihydroxyvitamin D Better Reflects Renal Parameters Than 25-hydoxyvitamin D in Patients with Glomerular Diseases[J].Int J Med Sci，2017，14（11）：1080-1087.
|
| [25] |
Gmciolli FG，Neves KR，Barreto F，et al.The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease[J].Kidney Int，2017，91（6）：1436-1446．
|
| [26] |
Sprague SM，Bellorin-Font E，Jorgetti V，et al.Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis[J].Am J Kidney Dis，2016，67（4）：559-566.
|
| [27] |
Xie SA，Zhang T，Wang J，et al.Matrix stiffness determines the phenotype of vascular smooth muscle cell in vitro and in vivo：role of DNA methyltransferase 1[J].Biomaterials，2018，155：203-216.
|
| [28] |
Bradley EW，Carpio LR，Olson EN，et al.Histone deacetylase 7（Hdac7）suppresses chondrocyte proliferation and βcatenin activity during endochondral ossification[J].J Biol Chem，2015，290（1）：118-126.
|
| [29] |
Zhang H，Chen J，Shen Z，et al.Indoxyl sulfate accelerates vascular smooth muscle cell calcifification via microRNA-29b dependent regula-tion of Wnt/beta-catenin signaling[J].Toxicol Lett，2018，284（1）：29-36.
|
| [30] |
Xu TH，Qiu XB，Sheng ZT，et al.Restoration of microRNA-30b expression alleviates vascular calcifification through the mTOR signaling pathway and autophagy[J].J Cell Physiol，2019，234（8）：14306-14318.
|
| [31] |
Lee CT，Lee YT，Tain YL，et al.Circulating microRNAs and vascular calcifification in hemodialysis patients[J].J Int Med Res，2019，47（7）：2929-2939.
|
| [32] |
Wang Y，Luo W，Han J，et al.MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy[J].Nat Commun，2020，11（1）：2148.
|
| [33] |
Viaene L，Behets GJ，Heye S，et al.Inflammation and the bone-vascular axis in end-stage renal disease[J].Osteoporos Int，2016，27（2）：489-497.
|
| [34] |
Buendía P，Montes de Oca A，Madueno JA，et al.Endothelial microparticles mediate inflammation-induced vascular calcification[J].FASEB J，2015，29（1）：173-181.
|
| [35] |
Liu Y，Wang WM，Zhang XL，et al.AGE/RAGE promotes the calcifification of human aortic smooth muscle cells via the Wnt/β-catenin axis[J].Am J Transl Res，2016，8（11）：4644-4656.
|
| [36] |
Hénaut L，Sanchez-Nino MD，Aldamiz-Echevarría Castillo G，et al.Targeting local vascular and systemic consequences of inflflammation on vascular and cardiac valve calcifification[J].Expert Opin Ther Targets，2016，20（1）：89-105.
|
| [37] |
Chao CT，Yeh HY，Tsai YT，et al.Natural and non-natural antioxidative compounds：potential candidates for treatment of vasc-ular calcififi-cation[J].Cell Death Discov，2019，13（5）：145.
|
